mpla qs21 Search Results


sb-as2  (SmithKline Beecham Clinical)
90
SmithKline Beecham Clinical sb-as2
Sb As2, supplied by SmithKline Beecham Clinical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mpla+qs21/us07271156-966-31-32?v=SmithKline+Beecham+Clinical
Average 90 stars, based on 1 article reviews
sb-as2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
sb-as2  (SmithKline Corporation)
90
SmithKline Corporation sb-as2
Sb As2, supplied by SmithKline Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mpla+qs21/us11746138-599-31-32?v=SmithKline+Corporation
Average 90 stars, based on 1 article reviews
sb-as2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
as01 b  (Glaxo Smith)
86
Glaxo Smith as01 b
Rabbit immunogenicity. A) Overview of rabbit immunogenicity studies. 3 groups of 4 rabbits were immunized with unmodified parent VLPs or B4G + ST6-modified VLPs. VLPs were produced by transfecting plasmids expressing JR-FL SOS gp160ΔCT E168K and MuLV gag in 293T cells, with and without B4G and ST6 expression plasmids, and formulated in <t>AS01</t> <t>B</t> or Adjuplex. The week of each immunization is indicated along with the bleeds, taken two weeks thereafter. Binding titers of rabbit vaccine sera and human HIV+ plasmas to B) gp120 and gp41 and C) VLPs were measured by ELISA. Rabbits from the current study are labeled R13 – R24. Rabbits from previous studies are 613, gp120 and bald VLP. 1648 and 1686 are HIV-1+ human plasmas. In part C (refer to key), VLPs bearing JR-FL Env and SIV Gag measure anti-Env abs (red circles), VLPs made using MuLV Gag only measure anti-gag abs (purple triangles) and VLPs made using SIV Gag (blue squares). All 3 types of VLPs measure host-VLP membrane reactivity. Each point was representative of data derived from at least 2 repeats.
As01 B, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mpla+qs21/pmc11442005-751-5-7?v=Glaxo+Smith
Average 86 stars, based on 1 article reviews
as01 b - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
qs21/mpl adjuvant with emulsion  (SmithKline Beecham Clinical)
90
SmithKline Beecham Clinical qs21/mpl adjuvant with emulsion
Rabbit immunogenicity. A) Overview of rabbit immunogenicity studies. 3 groups of 4 rabbits were immunized with unmodified parent VLPs or B4G + ST6-modified VLPs. VLPs were produced by transfecting plasmids expressing JR-FL SOS gp160ΔCT E168K and MuLV gag in 293T cells, with and without B4G and ST6 expression plasmids, and formulated in <t>AS01</t> <t>B</t> or Adjuplex. The week of each immunization is indicated along with the bleeds, taken two weeks thereafter. Binding titers of rabbit vaccine sera and human HIV+ plasmas to B) gp120 and gp41 and C) VLPs were measured by ELISA. Rabbits from the current study are labeled R13 – R24. Rabbits from previous studies are 613, gp120 and bald VLP. 1648 and 1686 are HIV-1+ human plasmas. In part C (refer to key), VLPs bearing JR-FL Env and SIV Gag measure anti-Env abs (red circles), VLPs made using MuLV Gag only measure anti-gag abs (purple triangles) and VLPs made using SIV Gag (blue squares). All 3 types of VLPs measure host-VLP membrane reactivity. Each point was representative of data derived from at least 2 repeats.
Qs21/Mpl Adjuvant With Emulsion, supplied by SmithKline Beecham Clinical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mpla+qs21/pm09952361-32-26-30?v=SmithKline+Beecham+Clinical
Average 90 stars, based on 1 article reviews
qs21/mpl adjuvant with emulsion - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
mpla qs21  (Croda International Plc)
96
Croda International Plc mpla qs21
Rabbit immunogenicity. A) Overview of rabbit immunogenicity studies. 3 groups of 4 rabbits were immunized with unmodified parent VLPs or B4G + ST6-modified VLPs. VLPs were produced by transfecting plasmids expressing JR-FL SOS gp160ΔCT E168K and MuLV gag in 293T cells, with and without B4G and ST6 expression plasmids, and formulated in <t>AS01</t> <t>B</t> or Adjuplex. The week of each immunization is indicated along with the bleeds, taken two weeks thereafter. Binding titers of rabbit vaccine sera and human HIV+ plasmas to B) gp120 and gp41 and C) VLPs were measured by ELISA. Rabbits from the current study are labeled R13 – R24. Rabbits from previous studies are 613, gp120 and bald VLP. 1648 and 1686 are HIV-1+ human plasmas. In part C (refer to key), VLPs bearing JR-FL Env and SIV Gag measure anti-Env abs (red circles), VLPs made using MuLV Gag only measure anti-gag abs (purple triangles) and VLPs made using SIV Gag (blue squares). All 3 types of VLPs measure host-VLP membrane reactivity. Each point was representative of data derived from at least 2 repeats.
Mpla Qs21, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mpla+qs21/pmc12368178-157-30-33?v=Croda+International+Plc
Average 96 stars, based on 1 article reviews
mpla qs21 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

Image Search Results


Rabbit immunogenicity. A) Overview of rabbit immunogenicity studies. 3 groups of 4 rabbits were immunized with unmodified parent VLPs or B4G + ST6-modified VLPs. VLPs were produced by transfecting plasmids expressing JR-FL SOS gp160ΔCT E168K and MuLV gag in 293T cells, with and without B4G and ST6 expression plasmids, and formulated in AS01 B or Adjuplex. The week of each immunization is indicated along with the bleeds, taken two weeks thereafter. Binding titers of rabbit vaccine sera and human HIV+ plasmas to B) gp120 and gp41 and C) VLPs were measured by ELISA. Rabbits from the current study are labeled R13 – R24. Rabbits from previous studies are 613, gp120 and bald VLP. 1648 and 1686 are HIV-1+ human plasmas. In part C (refer to key), VLPs bearing JR-FL Env and SIV Gag measure anti-Env abs (red circles), VLPs made using MuLV Gag only measure anti-gag abs (purple triangles) and VLPs made using SIV Gag (blue squares). All 3 types of VLPs measure host-VLP membrane reactivity. Each point was representative of data derived from at least 2 repeats.

Journal: Glycobiology

Article Title: Impact of glycan depletion, glycan debranching and increased glycan charge on HIV-1 neutralization sensitivity and immunogenicity

doi: 10.1093/glycob/cwae063

Figure Lengend Snippet: Rabbit immunogenicity. A) Overview of rabbit immunogenicity studies. 3 groups of 4 rabbits were immunized with unmodified parent VLPs or B4G + ST6-modified VLPs. VLPs were produced by transfecting plasmids expressing JR-FL SOS gp160ΔCT E168K and MuLV gag in 293T cells, with and without B4G and ST6 expression plasmids, and formulated in AS01 B or Adjuplex. The week of each immunization is indicated along with the bleeds, taken two weeks thereafter. Binding titers of rabbit vaccine sera and human HIV+ plasmas to B) gp120 and gp41 and C) VLPs were measured by ELISA. Rabbits from the current study are labeled R13 – R24. Rabbits from previous studies are 613, gp120 and bald VLP. 1648 and 1686 are HIV-1+ human plasmas. In part C (refer to key), VLPs bearing JR-FL Env and SIV Gag measure anti-Env abs (red circles), VLPs made using MuLV Gag only measure anti-gag abs (purple triangles) and VLPs made using SIV Gag (blue squares). All 3 types of VLPs measure host-VLP membrane reactivity. Each point was representative of data derived from at least 2 repeats.

Article Snippet: VLPs were formulated either in AS01 B (Glaxo SmithKline, consisting of liposomes containing deacylated monophosphoryl lipid A and QS-21) or Adjuplex (Advanced BioAdjuvants, consisting of purified lecithin and carbomer homopolymer).

Techniques: Immunopeptidomics, Modification, Produced, Expressing, Binding Assay, Enzyme-linked Immunosorbent Assay, Labeling, Membrane, Derivative Assay